Filed pursuant to Rule 424(b)(5)
Registration File No. 333-283284
Prospectus Supplement
(to Prospectus Supplements dated December 19,
2024 and December 27, 2024
to Prospectus dated November 26, 2024)
Up to $14,275,000
Shares of Common Stock
This prospectus supplement
(this “Prospectus Supplement”) amends and supplements the information in the prospectus, dated November 26, 2024 (the “Prospectus”),
filed with the Securities and Exchange Commission as a part of our registration statement on Form S-3 (File No. 333-283284), as previously
supplemented by our prospectus supplements, dated December 19, 2024 and December 27, 2024 (such prospectus supplements together with the
Prospectus, the “Prior Prospectus”), relating to the offer and sale of shares of our common stock having an aggregate offering
price of up to $14,275,000 pursuant to the terms of an At the Market Sales Agreement, dated December 19, 2024, with A.G.P./Alliance Global
Partners (“A.G.P.”), as amended on January 31, 2025 (the “Sales Agreement”). This Prospectus Supplement should
be read in conjunction with the Prior Prospectus, and is qualified by reference thereto, except to the extent that the information herein
amends or supersedes the information contained in the Prior Prospectus. This Prospectus Supplement is not complete without, and may only
be delivered or utilized in connection with, the Prior Prospectus and any future amendments or supplements thereto. This Prospectus Supplement
amends and/or supplements only those sections of the Prior Prospectus as listed in this Prospectus Supplement, and all other sections
of the Prior Prospectus remain as is.
We are an “emerging
growth company” and “smaller reporting company” as defined under U.S. federal securities laws and are subject to reduced
public company reporting requirements. Our common stock is listed on the Nasdaq Capital Market (“Nasdaq”) under the symbol
“AIRE.” The last sale price of our common stock, as reported on Nasdaq on January 30, 2025, was $1.52 per share.
As of January 31, 2025, the
aggregate market value of the voting and non-voting common equity held by non-affiliates, computed by reference to the price at which
the common equity was last sold on December 26, 2024 of $3.58, was $43,520,130.38, based on 46,054,182 shares of outstanding common stock
as of January 31, 2025, of which 12,156,461 shares were held by non-affiliates. Pursuant to General Instruction I.B.6 of Form S-3, in
no event will we sell securities in a public primary offering with a value exceeding more than one-third of our public float in any 12-month
period so long as our public float remains below $75.0 million. During the 12 calendar months prior to and including the date of this
Prospectus Supplement, we have sold no securities pursuant to General Instruction I.B.6 of Form S-3.
Investing in our securities
involves a high degree of risk. See “Risk Factors” beginning on page S-5 of the Prospectus Supplement dated December 19, 2024
and the risk factors incorporated by reference into this Prospectus Supplement and the Prior Prospectus, as they may be amended, updated
or modified periodically in our reports filed with the Securities and Exchange Commission.
Neither the Securities
and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy
or accuracy of this Prospectus Supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.
A.G.P.
The date of this Prospectus Supplement is January
31, 2025
Dilution
If you invest in our securities
in this offering, your ownership interest will be diluted to the extent of the difference between the offering price per share paid by
the purchaser in this offering and our pro forma as adjusted net tangible book value per share immediately after this offering.
Our historical net tangible
book deficit as of September 30, 2024 was approximately $(3.29) million, or $(0.07) per share of common stock. We calculate tangible book
value (deficit) per share by dividing our total tangible assets, less total liabilities, by the number of shares of our common stock outstanding
as of September 30, 2024.
After giving effect to the
issuance of 483,215 shares of our common stock in connection with our acquisition of AiChat, our pro forma net tangible book deficit as
of September 30, 2024 would have been approximately $(3.29) million, or $(0.07) per share.
After giving effect to the
offering of $14,275,000 of our common stock at an assumed offering price of $3.90 per share, the floor price at which a share of our common
stock may be sold pursuant to the sales agreement, and after deducting fees of A.G.P. and estimated offering expenses payable by us, our
pro forma as adjusted net tangible book value as of September 30, 2024 is approximately $10.42 million, or $0.21 per share of common stock.
This represents an immediate increase in net tangible book deficit of $0.28 per share of common stock, to existing stockholders and an
immediate dilution in net tangible book value of $3.69 per share of common stock, to purchasers of common stock in this offering at an
assumed offering price of $3.90 per share.
The following table illustrates
this per share dilution:
Assumed offering price per share | |
| | | |
$ | 3.90 | |
Pro forma net tangible book deficit per share as of September 30, 2024 | |
$ | (0.07 | ) | |
| | |
Increase in net tangible book deficit per share attributable to this offering | |
$ | 0.28 | | |
| | |
Pro forma as adjusted net tangible book value per share as of September 30, 2024, after giving effect to this offering | |
| | | |
$ | 0.21 | |
Dilution per share to new investors purchasing shares in this offering | |
| | | |
$ | 3.69 | |
The
foregoing discussion and table illustrates the dilution in net tangible book value per share to new investors as of September 30, 2024,
and assumes for illustrative purposes that an aggregate of 3,660,256 shares of our common stock are offered during the term of the sales
agreement with A.G.P. at a price of $3.90 per share, the floor price which a share of our common stock may be sold pursuant to the sales
agreement, for aggregate gross proceeds of $14,275,000. The foregoing table illustrates this calculation on a per share basis. The pro
forma as adjusted information is illustrative only and will adjust based on the actual price to the public, the actual number of shares
sold and other terms of the offering determined at the time shares of our common stock are sold pursuant to this prospectus supplement,
subject to the floor price which a share of our common stock may be sold pursuant to the sales agreement of $3.90 per share. The shares
sold in this offering, if any, will be sold from time to time at various prices. An increase of $1.00 per share in the price at which
the shares are sold from the assumed offering price of $3.90 per share shown in the table above, assuming all of our common stock in the
aggregate amount of $14,275,000 during the term of the sales agreement with A.G.P. is sold at that price, would increase our as pro forma
adjusted net tangible book value per share after the offering to $0.21 per share and would increase the dilution in net tangible book
value per share to new investors in this offering to $3.69 per share, after deducting commissions and estimated aggregate offering expenses
payable by us. This information is supplied for illustrative purposes only. We will not offer and sell shares in excess of any amount
that would cause the number of our outstanding shares to exceed the number of shares then authorized to be issued under our certificate
of incorporation.
The above discussion and table
are based on 45,570,967 shares of our common stock issued and outstanding as of September 30, 2024, except as described, and excludes,
as of such date:
|
● |
3,697,961 shares of common stock available for future issuance under the 2022 Plan; |
|
|
|
|
● |
2,400,000 shares of common stock issuable upon exercise of the Follow-On Warrants at $5.00 per share; and |
|
|
|
|
● |
1,700,884 shares of common stock issuable upon exercise of the GEM Warrants at $371.90 per share. |
The discussion and table above
assume no exercise of outstanding warrants. To the extent that warrants are exercised, you may experience further dilution. In addition,
we may choose to raise additional capital due to market conditions or strategic considerations even if we believe we have sufficient funds
for our current or future operating plans. To the extent that additional capital is raised through the sale of equity or convertible debt
securities, the issuance of these securities could result in further dilution to our stockholders.
reAlpha Tech (NASDAQ:AIRE)
Historical Stock Chart
From Jan 2025 to Feb 2025
reAlpha Tech (NASDAQ:AIRE)
Historical Stock Chart
From Feb 2024 to Feb 2025